Ann: ImpediMed announces leadership and Board changes, page-22

I personally think this is the typical good news that the market takes as bad news. We cannot know how the sales have been shaping up, or the future will shape up other than what has been released. However there were, IMO, red flags over RV's statements both in the statements made in the first webinar following the NCCN update, and (with board involvement) the attitude to a cap raise that was not yet required, and that ignored shareholders interests, and recently in the way RV decided not to tell us he was keeping quiet about (non existent or very low level?) PP updates after the board was punted, which seemed like a tantrum. Those were not the actions of a CEO I would personally want to be relying upon as a shareholder, with power games being played etc it seemed to me. However that is not to say that RV would not be a brilliant CEO if the incentives were properly aligned with contribution to the business, and with a tough lawmaking board that would take no BS - which in this case they were not at all IMO.

The board equally presided over the incentive scheme that allowed RV to (arguably to some) talk down the market before his significant incentives were locked in, and there was no reaction to this from the board at the time, or statement. And these incentives were for just getting the job after the hard work and good luck were factored in. The board in aggregate seemed a bunch of sheep.

So even if the SP was to fall again to 10c, AFAIAC - the company is in far better shape now.

And even better we have board members who make tough decisions, and possibly have a potentially great CEO who can be tested before being given the permanent job.

All IMO - happy shareholder now!